BryanRKestenbaumMD
Nephrology • Seattle, WAAssociate Professor, Medicine, University of Washington School of Medicine
Are you Dr. Kestenbaum?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
PO Box
# 1959
Seattle, WA 98195Phone+1 206-598-5068Fax+1 206-744-6985
Summary
- Dr. Bryan Kestenbaum, MD is a nephrologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Ohio. He is affiliated with UW Medicine/University of Washington Medical Center and UW Medicine/Harborview Medical Center.
Education & Training
University of WashingtonFellowship, Nephrology, 1999 - 2003
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1995 - 1998
University of Massachusetts Medical SchoolClass of 1995
Certifications & Licensure
WA State Medical License 1999 - 2026
OH State Medical License 1996 - 2000
Clinical Trials
- Individualized Response to Vitamin D Treatment Study Start of enrollment: 2017 Jan 11
- Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease Start of enrollment: 2018 Nov 14
Publications & Presentations
PubMed
- Proximal Tubule Secretory Clearance, Injury, and Kidney Viability in Cirrhosis.Michael L Granda, Eric Luitweiler, David K Prince, Andrew S Allegretti, Cary Paine
Clinical and Translational Gastroenterology. 2024-11-01 - The association of microvascular disease and endothelial dysfunction with vertebral trabecular bone mineral density : The MESA study.Joshua I Barzilay, Petra Buzkova, Suzette J Bielinski, Mary Frances Cotch, Bryan Kestenbaum
Osteoporosis International. 2024-09-01 - Randomized Crossover Clinical Trial of Nicotinamide Riboside and Coenzyme Q10 on Metabolic Health and Mitochondrial Bioenergetics in CKD.Armin Ahmadi, Ana P Valencia, Gwénaëlle Begue, Jennifer E Norman, Sili Fan
Medrxiv. 2024-08-23
Authored Content
- Heroin Use Is Associated with AA-Type Kidney Amyloidosis in the Pacific NorthwestJune 2018
- Association of Vitamin D Metabolites with Arterial Function in the Hemodialysis Fistula Maturation StudyMarch 2017
- Association of Vitamin D Metabolites with Arterial Function in the Hemodialysis Fistula Maturation StudyMarch 2017
Press Mentions
Atrial Fibrillation Risk Rises with Decreasing Kidney FunctionAugust 11th, 2017
Stuck in a Bind with Phosphate BindersDecember 8th, 2017
Grant Support
- Phosphorus And Vitamin D Metabolism And Cardiovascular Outcomes: The Multi-EthniNational Heart, Lung, And Blood Institute2010–2012
- Serum Calcification Activity In Patients With Chronic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Mineral Metabolism And Cardiovascular Risk Among Older AdultsNational Heart, Lung, And Blood Institute2007–2009
- Cardiac Outcomes Associated With Renal OsteodystrophyNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2007
